MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,089,000 | -85.8% | 96,049 | -82.1% | 0.00% | -86.4% |
Q1 2020 | $7,667,000 | -47.7% | 535,759 | -0.5% | 0.02% | -37.1% |
Q4 2019 | $14,658,000 | -0.9% | 538,289 | +4.2% | 0.04% | -7.9% |
Q3 2019 | $14,790,000 | +4.6% | 516,599 | +1.5% | 0.04% | -20.8% |
Q2 2019 | $14,141,000 | -15.1% | 509,049 | +1.5% | 0.05% | -21.3% |
Q1 2019 | $16,653,000 | +14.0% | 501,589 | -0.2% | 0.06% | 0.0% |
Q4 2018 | $14,611,000 | -36.7% | 502,609 | +0.2% | 0.06% | -25.6% |
Q3 2018 | $23,069,000 | +24.3% | 501,499 | +1.0% | 0.08% | +156.2% |
Q2 2018 | $18,559,000 | +22.2% | 496,629 | -3.4% | 0.03% | +18.5% |
Q1 2018 | $15,189,000 | -8.8% | 513,999 | +6.0% | 0.03% | -6.9% |
Q4 2017 | $16,655,000 | -0.3% | 484,919 | +5.1% | 0.03% | -6.5% |
Q3 2017 | $16,699,000 | +37.1% | 461,559 | -2.0% | 0.03% | +29.2% |
Q2 2017 | $12,176,000 | +33.3% | 471,189 | -1.0% | 0.02% | +33.3% |
Q1 2017 | $9,135,000 | +14.2% | 475,759 | -0.9% | 0.02% | +5.9% |
Q4 2016 | $8,000,000 | -19.8% | 479,919 | -1.0% | 0.02% | -19.0% |
Q3 2016 | $9,979,000 | -32.3% | 484,889 | +0.7% | 0.02% | -34.4% |
Q2 2016 | $14,732,000 | -19.6% | 481,449 | -1.7% | 0.03% | -22.0% |
Q1 2016 | $18,328,000 | +17.9% | 489,649 | +35.9% | 0.04% | +17.1% |
Q4 2015 | $15,545,000 | +12.3% | 360,180 | -2.5% | 0.04% | +2.9% |
Q3 2015 | $13,848,000 | +6.2% | 369,490 | -3.7% | 0.03% | +13.3% |
Q2 2015 | $13,038,000 | -7.8% | 383,590 | -3.9% | 0.03% | -9.1% |
Q1 2015 | $14,135,000 | +2.0% | 399,300 | -1.9% | 0.03% | 0.0% |
Q4 2014 | $13,858,000 | -18.5% | 406,870 | -7.7% | 0.03% | -19.5% |
Q3 2014 | $17,000,000 | +2.9% | 440,770 | +3.8% | 0.04% | +7.9% |
Q2 2014 | $16,520,000 | +19.1% | 424,450 | +4.7% | 0.04% | +11.8% |
Q1 2014 | $13,866,000 | +263.1% | 405,550 | +122.8% | 0.03% | +277.8% |
Q4 2013 | $3,819,000 | -12.2% | 182,050 | -1.6% | 0.01% | -25.0% |
Q3 2013 | $4,350,000 | – | 185,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |